منابع مشابه
Molecular genetics of gynecologic cancer.
During the past decades, the expansion of molecular biology has had a pivotal role in understanding the basis of cancer development and progression. In addition, real advances have been made in the application of DNA recombinant technology to cancer therapy and patient management. In gynecologic oncologic fields, there are also many investigations to explore the basic pathogenesis of gynecologi...
متن کاملMolecular features that predict the response to antimetabolite chemotherapies
BACKGROUND Antimetabolite chemotherapeutic agents that target cellular metabolism are widely used in the clinic and are thought to exert their anti-cancer effects mainly through non-specific cytotoxic effects. However, patients vary dramatically with respect to treatment outcome, and the sources of heterogeneity remain largely unknown. METHODS Here, we introduce a computational method for ide...
متن کاملCastration-resistant Prostate Cancer— Chemotherapies and Molecular Targets
© Touch MEdical MEdia 2013 Abstract castration-resistant prostate cancer (cRPc) has a poor prognosis: current chemotherapeutic approaches ultimately result in resistance and are associated with survival rates of less than 2 years. however, the last decade has seen an expansion in the number of therapeutic options for cRPc and the regulatory approval of several agents, including the chemotherapy...
متن کاملPredictive biomarkers for chemotherapies in pancreatic cancer
Pancreatic cancer is associated with high rates of mortality especially due to advanced stages of diagnosis. Adjuvant chemotherapy role is thus essential in the attempt to downstage the tumoral grade. In cases of locally advanced tumors, this step could be followed by curative surgical resection. Characterization of predictor biomarkers for adjuvant chemotherapy has drawn increasing interest in...
متن کاملGynecologic malignancy in pregnancy
Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic proce...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chemotherapy: Open Access
سال: 2017
ISSN: 2167-7700
DOI: 10.4172/2167-7700.1000242